findmyKOL

Steven Manders, MD

Basic profile

Cooper Medical School of Rowan University

ORCIDNone on fileNPI
RegionMarlton, NJ · NortheastSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Steven Manders is a Dermatology physician affiliated with Cooper Medical School of Rowan University. OpenAlex indexes 38 publications with 790 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
38publications

Distinct works indexed by OpenAlex.

790citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
23companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

10000 Sagemore Dr Ste 10101
Marlton, NJ 080533944

Telephone

856-596-0111

Provider last certified this registry record 17 Jun 2025.

View the NPPES registry record

Industry payments

23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    29.4%
    Azole Antifungal16.4%
    Ketoconazole100%
    Part D91 patients
    Nitroimidazole Antimicrobial4.1%
    Metronidazole100%
    Part D31 patients

    + 4 more classes in this area

  • Dermatology

    23.1%
    Corticosteroid12.4%
    Triamcinolone Acetonide89%Triamcinolone acetonide12%
    Part D + Part B86 patients
    Interleukin-4 Receptor alpha Antagonist4.9%
    Dupixent Pen52%Dupixent Syringe48%
    Part D<11 patients

    + 3 more classes in this area

  • Sensory organs

    20.1%
    Corticosteroid20.1%
    Hydrocortisone47%Betamethasone Diprop Augmented22%Clobetasol Propionate13%Betamethasone Dipropionate11%Alclometasone Dipropionate7%
    Part D78 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

33 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”